Companies
- Companies
- Company details
Pharmalicensing
Pharmalicensing.com - the leading global resource for partnering, licensing, and business development.
The company in detail
Profile
Pharmalicensing is the leading global resource for partnering, licensing, and business development within the life science and biopharmaceutical industries. Our unique services complement and enhance business development activity throughout the deal-making process - from finding the perfect partner to closing the deal.
Licensing
For licensors - we help innovators market their licensing opportunities to decision makers at licensee organisations worldwide, including bigpharma, biotech companies, spin-offs and academic institutions.
For licensees - we facilitate global pharmaceutical/ biotechnology companies, investors, and research organisations in identifying, tracking and securing of technology opportunities, actively communicating licensing needs, and forming better partnerships.
In addition, we offer a comprehensive partner search, providing clients with a bespoke prospect list of partner search companies entirely based on their partnering criteria. Following client approval this prospect list can then be converted to a ‘hot list' where we will actively introduce our clients, using the Pharmalicensing name, to one another to begin initial discussions.
For outsourced service providers - we market service providers, their skills and expertise to decision makers in pharmaceutical/biotechnology companies worldwide. This industry is becoming increasingly reliant on the expertise of third parties, in order to reduce the time to market and provide access to know-how worldwide.
Pharmalicensing provides a unique approach to business development:
- Access to the largest business development community
- A broadcasting platform used by over 190, 000 users per month
- Direct to potential business partners
- Comprehensive access to business intelligence resources
Listing industry news, timely biopharma reports and details of forthcoming licensing and partnering events, Pharmalicensing provides its users with the relevant mix of intelligence they require in order to strengthen and progress their business development activities further.
Out-licensing
Powder spray providing a benign mucosal barrier over the entire throat, combating the reflux related symptoms of stomach acid and enzymes in the throat, utilizing a purified, organic, safe and effective natural compound. More
Our Australian based clients have developed a second generation antisense inhibitor to human CD49d, a subunit of VLA-4, that has shown in Phase II studies to be effective in reducing brain lesions in patients with the relapsing form of multiple sclerosis. More
Our client is looking for partners to further develop and commercialize stem cells, sourced from adipose tissue for the treatment of regenerative medicine and ageing. More
Our client is an academic institution that has developed a unique anti-microbial monocaprin emulsion with key cleaning solvent properties indicated primarily for the preparation and protection of food and cosmetics. More
Our Eastern based client has identified a group of compounds that are effective in the treatment of neuropathic chronic pain and have no CNS-related side effects. More
This transbuccal (tiny spray on the inside of the cheek) nicotine replacement therapy (NRT) is delivered rapidly into the bloodstream where it provides immediate relief from nicotine cravings. More
This unique therapeutic topical agent is capable of healing wounds/scars/burns and has many potential uses in the dermatological, dental and hospital/surgery market. More
The omega-3 fatty acids are extracted from New Zealand green lipped mussels and developed into oils for use in anti-inflammatory compounds by our UK based clients. More
Our clients are sourcing and developing unique omega-3 fatty acids from green lipped mussels for the treatment of joints, asthma and dermatitis in animals. More
Our client has developed a solution to successfully prevent unwanted earwax buildup. More
Our UK based client has developed and patented a unique treatment for alopecia and is seeking co-development partners. More
A biosimilar specialist has manufactured the rhFSH API and is now looking for a partner to fully develop it into a biosimilar comparable to that of Gonal-f® More
Polymeric antimicrobial effective against 99.9% of Gram + and Gram – bacteria. Suitable for a range of applications including cleaning sprays, sanitizers, textiles, plastics, resins, rubber, paints, coatings, and waxes. More
Long standing experienced South American Laboratory is seeking to expand its distribution of prescription products into Nigeria, Kenya and Angola. More
Scientists at the forefront of regenerative medicine based at the Biomatcell Vinn Excellence Center of Biomaterials have identified this small molecule platform with these unique osteogenic differentiating properties and are now looking to develop them. More
The plant milking technology is capable of producing high value active pharmaceutical compounds More
Women’s health specialists have created a non invasive class IIa medical device for the successful control of stress related incontinence. More
Using a unique resin-based topical delivery system, this product provides more effective local pain relief and longer periods of sustained relief compared to existing products. More
The ‘green technology’ allows the extraction of cosmetically active compounds from plants using root exudation without harming the plants involved. More
In-licensing
Our global animal health clients seek new anti-parasitic compounds to treat external parasites affecting companion animals (dogs, cats etc.) and food producing animals (e.g. pigs, cattle, chicken). More
Our analgesic specialists are seeking a new, innovative and novel patch product for the treatment of pain to add to their portfolio. More
Our leading apoptosis focused clinical stage drug development company seeks to in-license or acquire early stage clinical projects or technologies at phase I or II in the areas of either oncology or neurology. More
Our Portuguese clients are seeking to in-license prescription based hospital products indicated for the treatment of oncology, immunology and orphan diseases. More
Our client is a leading long standing contract manufacturer with expertise in producing pharmaceuticals, nutraceuticals and medicated feed products for the animal health industry. More
Services
A one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
more
Covering a magnitude of biopharmaceutical topics from licensing processes to management strategies and therapeutic overviews the store offers a diverse collection of biopharma and pharmaceutical repor
more
Our profiling service maximizes your potential of finding the most suitable partner for your opportunities by targeting our focused global business development and licensing audience.
more
Based upon the experience and completion of many real life successful deals, Pharmalicensing provides the appropriate commercial support you require, whatever stage of the process you are at
more
The Partnering Search offers advanced and enhanced partnering support. Actively working for you, our service enables you to utilize our knowledge and expertise. A fully comprehensive solution designed
more
Our client is a leading long standing contract manufacturer with expertise in producing pharmaceuticals, nutraceuticals and medicated feed products for the animal health industry.
more
Press Releases
(20th May 2013) York, UK & Manchester, UK -- May 20th, 2013 – Pharmalicensing, a division of IP Technology Exchange, Inc, today announced it has agreed a partnership with Bionow, the membership company representing the interests of life science organisations across the N More
(5th Jan 2012) Tampa, FL -- (Business Wire) – January 5, 2012 – Innovaro, Inc (NYSE Amex: INV), a leading IP licensing and innovation services company, is pleased to announce that its client CUI Global, Inc. (formerly Waytronx) has completed the sale of selected patents More
(28th Jan 2010) The recent signing of a co-promotional agreement between myM-link and Medical Device Licensing (a division of UTEK Europe, Ltd.), whereby myM-link will actively promote partnering opportunities from Medical Device Licensing’s client companies directly to More
(14th Jan 2010) Tampa, FL -- (Business Wire) – January 12, 2010 -- UTEK Corporation (NYSE Amex: UTK), a leading IP licensing and innovation services company, is pleased to announce a new pricing model for its Pharmalicensing online service; the pricing will be effective More
(4th Jan 2008) UTEK Corporation (LSE-AIM & AMEX:UTK), an open innovation company focused on technology transfer, has completed acquisition of Pharmalicensing, Ltd. More
(25th Jul 2007) Today Pharmalicensing launches the 3rd edition of its top selling report 'The Licensing Agreement in Pharmaceutical Business Development'. More
(23rd Jul 2007) Pharmalicensing now offers in-depth and involved consulting to guide you through the process of licensing More
(15th Jan 2007) York, UK, 15 Jan 2006 - Pharmaceutical research and development in China is being constantly accelerated by successful clinical trials, a growing number of established R&D specialist companies and scientific technical expertise More
(1st Dec 2006) With deals increasing in terms of number and value, partnering at early stage development is now an integral component of pharmaceutical and biotech business strategy. Pharmalicensing has revised and updated its successful Early Stage report More
(6th Jun 2006) Pharmalicensing launches revised versions of its Deals Briefings with up-to-date data More
Related Reports
Market Research Reports provided by reports.iptechex.com
Jun 2006 - 1934 pages - $2,495
Jun 2006 - 434 pages - $2,495
Jun 2006 - 278 pages - $2,495
Jun 2006 - 1458 pages - $2,495
Jun 2006 - 634 pages - $2,495
Jun 2006 - 378 pages - $2,495
Jun 2006 - 492 pages - $2,495
Jan 2006 - 1126 pages - $2,495
Jun 2006 - 556 pages - $2,495
Jun 2006 - 602 pages - $2,495
Contact details
Head office
Pharmalicensing
A division of IP Technology Exchange, Inc.
Marlborough House, 1st Floor, Westminster Place
York Business Park
York
North Yorkshire
YO26 6RW
United Kingdom
A division of IP Technology Exchange, Inc.
Marlborough House, 1st Floor, Westminster Place
York Business Park
York
North Yorkshire
YO26 6RW
United Kingdom
Company figures
Formed: 1998
Related categories
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us